Dow Up 0.17% Nasdaq Up 0.29%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
49.89 3.21(6.88%) Aug 26, 4:00PM EDT
Prev Close:46.68
Open:46.82
Bid:46.52 x 100
Ask:54.90 x 200
1y Target Est:81.11
Beta:2.19
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:46.39 - 50.32
52wk Range:35.33 - 93.33
Volume:1,164,851
Avg Vol (3m):879,506
Market Cap:1.69B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 6.88%1.69B
IMMU278.91M
LRUSF57.12M
THLD242.21M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):116.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback